+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Aromasin"

From
From
Research Report on China's Exemestane Market, 2021-2025 - Product Thumbnail Image

Research Report on China's Exemestane Market, 2021-2025

  • Report
  • September 2021
  • 40 Pages
  • China
From
  • 3 Results (Page 1 of 1)
Loading Indicator

Aromasin (Exemestane) is a drug used to treat advanced stages of breast cancer in postmenopausal women. It is a type of hormone therapy, which works by blocking the production of estrogen in the body. Aromasin is also used to treat non-small cell lung cancer (NSCLC) in combination with other drugs. It is used to reduce the risk of cancer recurrence in patients who have already been treated with chemotherapy. Aromasin is a prescription drug and is available in tablet form. It is manufactured by Pfizer, Inc. and is available in the United States, Canada, and other countries. In the context of lung cancer drugs, Aromasin is used in combination with other drugs to treat NSCLC. It is used to reduce the risk of cancer recurrence in patients who have already been treated with chemotherapy. Aromasin is a prescription drug and is available in tablet form. Companies in the Aromasin market include Pfizer, Inc., AstraZeneca, Novartis, and Merck & Co. Show Less Read more